Back to Journals » Clinical Interventions in Aging » Volume 9

Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes

Total article views   HTML views PDF downloads Totals
9,805 Dovepress* 8,472+ 1,547 10,019
PubMed Central* 1,333 698 2,031
Totals 9,805 2,245 12,050
*Since 4 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar